Joel D. Kallich

Medical Sociology and Health Economics

BGS, MA, PhD (University of Iowa, Boston University) currently teaches at the Massachusetts College of Pharmacy and Health Sciences University and the University of Southern Maine, Osher Life Long Learning Institute. He also provides expert advice on data science and health economics to academia, advocacy organizations, government, medical device, pharmaceutical, and health care providers and insurers. 

     Clients have included the American Heart Association, Stanford and Tufts Universities, United Rheumatology, Bristol Meyers Squibb, Humacyte, ConcertoHealthAI, Flatiron Health, and Johnson & Johnson.  He has held leadership positions at Amgen, a global biotechnology firm where he successfully conducted clinical research to have a Patient-Reported Outcome (PRO) measure included in the European Medicine Agency summary of product characteristics. He also developed a data warehouse with over one million oncology patient EMRs for clinical development, epidemiology, safety, and business analysis. 

      Before Amgen, he worked at the RAND Corporation leading the research of genetics and organ distribution policies, codeveloped the Kidney Disease Quality of Life measurement tool, and evaluated the quality of mental health services provided by military treatment facilities. 

      From 1989-1990 Joel had many different federal and state governmental positions.  He led the team evaluating the US Organ Procurement and Transplant Network for the Office of the Inspector General for the Department of Health and Human Services, which won the Inspection of the Year.  He also built a data analysis department (Medicaid Policy Analysis), developed a prospective payment system for primary health care for low income and special needs populations, and advised the administration on developing reimbursement and funding mechanisms for universal health insurance in Massachusetts.